Zantac Cancer Lawsuits
The FDA has issued a new warning for customers of both the prescription and over-the-counter versions of Zantac (ranitidine). Zantac is currently being investigated for cancer risks associated with the drug after a recent test revealed that the commonly-used heartburn medication contains a carcinogenic chemical up to 3,000 times greater than the FDA’s daily intake limit. The carcinogenic chemical present in Zantac is known as N-nitrosodimethylamine (“NDMA”). If you’d like to discuss this issue, or feel you may have been affected, please fill out the form on the right, or click our chat button below. If you or a loved one were diagnosed with and cancers listed below after taking Zantac, you may be entitled to compensation by filing a Zantac lawsuit.
Zantac Recall? Zantac Cancer Risks? Enough Said. Ask Ed.
What is Zantac?
Zantac (ranitidine) belongs to a group of drugs called histamine-2 blockers. Ranitidine works by reducing the amount of acid your stomach produces.
Zantac is used to treat and prevent ulcers in the stomach and intestines. It also treats conditions in which the stomach produces too much acid, such as Zollinger-Ellison syndrome.
Zantac is also used to treat gastroesophageal reflux disease (GERD) and other conditions in which acid backs up from the stomach into the esophagus, causing heartburn.
*According to Drugs.com
Why Should I be Concerned?
Were You Diagnosed With Any of the Following Cancers After Taking Zantac for Any Reason:
- Stomach Cancer
- Colorectal Cancer
- Esophageal Cancer
- Liver Cancer
- Pancreatic Cancer
- Kidney Cancer
- Lung Cancer
- Pediatric Testicular Cancer
Global health regulators in Europe and the United States have issued a warning that Zantac contains a cancer-causing ingredient called NDMA. The Zantac warning came after a pharmacy in Connecticut discovered elevated levels of NDMA while testing Zantac.
Thus far, it has been reported that the levels of cancer-causing NDMA are anywhere from 3,000 to 26,000 times higher than the legally allowable limit set by the FDA.
Frequently Asked Questions About Zantac Cancer Lawsuits
What Is The Cancer Causing Ingredient In Zantac?
- N-nitrosodimethylamine (NDMA)
What Is NDMA in Zantac?
- The World Health Organization lists NDMA as a probable carcinogen, meaning it may cause cancer.
Is Rantildiline On The Recall List Too?
- Ranitidine (sold under brand names Zantac, Rani 2, and Ausran) is currently in the news because regulators have found that most formulations are contaminated. The drug has been recalled by the manufacturers in multiple countries.
Should I Keep Taking Zantac for My Heartburn?
- It has been recommended that patients who take prescription forms of the drug should talk to their doctor about alternatives.
The Zantac Cancer Lawsuit Consultation is FREE
If you or a loved one was diagnosed with cancer and have taken Zantac, you may be entitled to compensation, but your time to file a lawsuit may be limited.
Help is On The Way. Call Ed at 702-919-7025 NOW.
We understand it can be scary to consider exploring litigation. We have the resources to fight aggressively for your rights. When you hire us, you won’t pay us a penny for our services, unless we get money for you.